Vir Biotechnology, Inc. Common Stock (VIR) is a publicly traded Healthcare sector company. As of May 21, 2026, VIR trades at $8.89 with a market cap of $1.48B and a P/E ratio of -2.83. VIR moved +4.10% today. Year to date, VIR is +53.37%; over the trailing twelve months it is +87.74%. Its 52-week range spans $4.16 to $14.45. Analyst consensus is strong buy with an average price target of $20.63. Rallies surfaces VIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vir Biotechnology, Inc. Common Stock (VIR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VIR moved +4.10% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $8.89 |
| Market Cap | $1.48B |
| P/E Ratio | -2.83 |
| EPS | $-3.12 |
| Dividend Yield | 0.03% |
| 52-Week High | $14.45 |
| 52-Week Low | $4.16 |
| Volume | 1.70M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.50M |
| Net Income | $-442.72M |
| Gross Margin | 0.00% |
9 analysts cover VIR: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.63.